Increased levels and activities of matrix metallopeptidase (MMP)-2 and MMP-9 have been observed in sputum or BALF from asthma patients compared to those from controls, and these increases were proportional to the severity of the airway inflammation and the extent of airway remodeling [59–60]. Here, MMP9 is linked to asthma.